ANAVEX LIFE SCIENCES CORP. Financing Receivable (Deprecated 2012-01-31)
ANAVEX LIFE SCIENCES CORP. (AVXL) had Financing Receivable (Deprecated 2012-01-31) of $35.81 thousand as of 2011-12-31, per its 10-Q filed 2012-02-14.
Discontinued › Notes › Receivables
us-gaap:FinancingReceivable · last filed 2012-02-14
- 2011-12-31: Financing Receivable (Deprecated 2012-01-31) $35.81K.
- 2011-09-30: Financing Receivable (Deprecated 2012-01-31) $55.46K.
- 2010-09-30: Financing Receivable (Deprecated 2012-01-31) $0.00.
| Period end | Financing Receivable (Deprecated 2012-01-31) |
|---|---|
| 2011-12-31 | $35.81K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $55.46K 10-Q · filed 2012-02-14 |
| 2010-09-30 | $0.00 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |